Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks-Reference-Cited by-同舟云学术

Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks

Published:2009-04-03 Issue:13 Volume:18 Page:2328-2343
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Song Xuewen,Di Giovanni Valeria,He Ning,Wang Kairong,Ingram Alistair,Rosenblum Norman D.,Pei York

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/18/13/2328/17246283/ddp165.pdf

Reference56 articles.

1. Polycystic kidney disease;Harris;Annu. Rev. Med.,2009

2. Molecular pathogenesis of ADPKD: the polycystin complex gets complex;Ong;Kidney Int.,2005

3. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease;Paterson;J. Am. Soc. Nephrol.,2005

4. Cyst formation and growth in autosomal dominant polycystic kidney disease;Grantham;Kidney Int.,1987

5. A ‘two-hit’ model of cystogenesis in autosomal dominant polycystic kidney disease?;Pei;Trends Mol. Med.,2001

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CC2D1A causes ciliopathy, intellectual disability, heterotaxy, renal dysplasia, and abnormal CSF flow;Life Science Alliance;2024-08-21

2. Single-Base Substitution Causing Dual-Exon Skipping Event in PKD2 Gene: Unusual Molecular Finding from Exome Sequencing in a Patient with Autosomal Dominant Polycystic Kidney Disease;Journal of Clinical Medicine;2024-08-09

3. Reprogramming of Energy Metabolism in Human PKD1 Polycystic Kidney Disease: A Systems Biology Analysis;International Journal of Molecular Sciences;2024-06-29

5. Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease;Frontiers in Pharmacology;2024-05-23